43 related articles for article (PubMed ID: 29579156)
1. CEP55 promotes the proliferation and invasion of tumour cells via the AKT signalling pathway in osteosarcoma.
Xu L; Xia C; Sheng F; Sun Q; Xiong J; Wang S
Carcinogenesis; 2018 Apr; 39(4):623-631. PubMed ID: 29579156
[TBL] [Abstract][Full Text] [Related]
2. USP3 promotes osteosarcoma progression via deubiquitinating EPHA2 and activating the PI3K/AKT signaling pathway.
Li A; Wang S; Nie J; Xiao S; Xie X; Zhang Y; Tong W; Yao G; Liu N; Dan F; Shu Z; Liu J; Liu Z; Yang F
Cell Death Dis; 2024 Mar; 15(3):235. PubMed ID: 38531846
[TBL] [Abstract][Full Text] [Related]
3. TRAIP modulates the IGFBP3/AKT pathway to enhance the invasion and proliferation of osteosarcoma by promoting KANK1 degradation.
Li M; Wu W; Deng S; Shao Z; Jin X
Cell Death Dis; 2021 Aug; 12(8):767. PubMed ID: 34349117
[TBL] [Abstract][Full Text] [Related]
4. Cep55 regulation of PI3K/Akt signaling is required for neocortical development and ciliogenesis.
Rashidieh B; Shohayeb B; Bain AL; Fortuna PRJ; Sinha D; Burgess A; Mills R; Adams RC; Lopez JA; Blumbergs P; Finnie J; Kalimutho M; Piper M; Hudson JE; Ng DCH; Khanna KK
PLoS Genet; 2021 Oct; 17(10):e1009334. PubMed ID: 34710087
[TBL] [Abstract][Full Text] [Related]
5. The Calcium-Binding Protein S100A6 Accelerates Human Osteosarcoma Growth by Promoting Cell Proliferation and Inhibiting Osteogenic Differentiation.
Li Y; Wagner ER; Yan Z; Wang Z; Luther G; Jiang W; Ye J; Wei Q; Wang J; Zhao L; Lu S; Wang X; Mohammed MK; Tang S; Liu H; Fan J; Zhang F; Zou Y; Song D; Liao J; Haydon RC; Luu HH; He TC
Cell Physiol Biochem; 2015; 37(6):2375-92. PubMed ID: 26646427
[TBL] [Abstract][Full Text] [Related]
6. CEP55, serving as a diagnostic marker gene for osteosarcoma, triggers the JAK2-STAT3-MMPs axis.
Yan Y; He J; Cheng W
Ann Med Surg (Lond); 2024 Jan; 86(1):190-198. PubMed ID: 38222763
[TBL] [Abstract][Full Text] [Related]
7. High CEP55 expression is associated with poor prognosis in non-small-cell lung cancer.
Jiang C; Zhang Y; Li Y; Lu J; Huang Q; Xu R; Feng Y; Yan S
Onco Targets Ther; 2018; 11():4979-4990. PubMed ID: 30154666
[TBL] [Abstract][Full Text] [Related]
8. CEP55 Promotes Cell Motility via JAK2⁻STAT3⁻MMPs Cascade in Hepatocellular Carcinoma.
Li M; Gao J; Li D; Yin Y
Cells; 2018 Aug; 7(8):. PubMed ID: 30096813
[TBL] [Abstract][Full Text] [Related]
9. Prognostic and predictive value of super-enhancer-derived signatures for survival and lung metastasis in osteosarcoma.
Huang G; Zhang X; Xu Y; Chen S; Cao Q; Liu W; Fu Y; Jia Q; Shen J; Yin J; Zhang J
J Transl Med; 2024 Jan; 22(1):88. PubMed ID: 38254188
[TBL] [Abstract][Full Text] [Related]
10. Centrosomal Protein 55 (CEP55) Drives Immune Exclusion and Resistance to Immune Checkpoint Inhibitors in Colorectal Cancer.
Wangmo D; Gates TJ; Zhao X; Sun R; Subramanian S
Vaccines (Basel); 2024 Jan; 12(1):. PubMed ID: 38250876
[TBL] [Abstract][Full Text] [Related]
11. CEP55 as a Promising Immune Intervention Marker to Regulate Tumor Progression: A Pan-Cancer Analysis with Experimental Verification.
Wang G; Chen B; Su Y; Qu N; Zhou D; Zhou W
Cells; 2023 Oct; 12(20):. PubMed ID: 37887301
[TBL] [Abstract][Full Text] [Related]
12. α-catenin interaction with YAP/FoxM1/TEAD-induced CEP55 supports liver cancer cell migration.
Tang Y; Thiess L; Weiler SME; Tóth M; Rose F; Merker S; Ruppert T; Schirmacher P; Breuhahn K
Cell Commun Signal; 2023 Jun; 21(1):162. PubMed ID: 37381005
[TBL] [Abstract][Full Text] [Related]
13. Integrative bioinformatics and RNA sequencing based methodology results in the exploration of breast invasive carcinoma biomarkers.
Zhu Q; Zhang L; Sadiq FM; Abdel-Maksoud MA; Almutairi SM; Al-Qahtani WH; Gul J; Jamil M; Fatima I; Zia S
Am J Transl Res; 2023; 15(5):3067-3091. PubMed ID: 37303632
[TBL] [Abstract][Full Text] [Related]
14. A Comprehensive Pan-Cancer Analysis Identifies CEP55 as a Potential Oncogene and Novel Therapeutic Target.
Zaki MSA; Eldeen MA; Abdulsahib WK; Shati AA; Alqahtani YA; Al-Qahtani SM; Otifi HM; Asiri A; Hassan HM; Emam Mohammed Ahmed H; Dawood SA; Negm A; Eid RA
Diagnostics (Basel); 2023 May; 13(9):. PubMed ID: 37175004
[TBL] [Abstract][Full Text] [Related]
15. Circ_0136666 aggravates osteosarcoma development through mediating miR-1244/CEP55 axis.
Gao X; Xu N; Miao K; Huang G; Huang Y
J Orthop Surg Res; 2022 Sep; 17(1):421. PubMed ID: 36109749
[TBL] [Abstract][Full Text] [Related]
16. Long intergenic non-protein coding RNA 662 accelerates the progression of gastric cancer through up-regulating centrosomal protein 55 by sponging microRNA-195-5p.
Tao F; Qi L; Liu G
Bioengineered; 2022 Feb; 13(2):3007-3018. PubMed ID: 35037833
[TBL] [Abstract][Full Text] [Related]
17. Osteosarcoma and Metastasis.
Sheng G; Gao Y; Yang Y; Wu H
Front Oncol; 2021; 11():780264. PubMed ID: 34956899
[TBL] [Abstract][Full Text] [Related]
18. Identification of Prognostic Biomarkers and Correlation With Immune Infiltrates in Hepatocellular Carcinoma Based on a Competing Endogenous RNA Network.
Pu Z; Zhu Y; Wang X; Zhong Y; Peng F; Zhang Y
Front Genet; 2021; 12():591623. PubMed ID: 34093635
[TBL] [Abstract][Full Text] [Related]
19. The RNA-helicase DDX21 upregulates CEP55 expression and promotes neuroblastoma.
Putra V; Hulme AJ; Tee AE; Sun JQJ; Atmadibrata B; Ho N; Chen J; Gao J; Norris MD; Haber M; Kavallaris M; Henderson MJ; McCarroll J; Trahair T; Liu T; Liu PY
Mol Oncol; 2021 Apr; 15(4):1162-1179. PubMed ID: 33497018
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
